Vioxx to be removed from market within two months

Published: 2004-10-05 06:59:00

Updated: 2004-10-05 06:59:00

Following the September 30 announcement of Merck &. Co. to remove Vioxx (rofecoxib) from the United States and worldwide market, MSD Korea informed the Korea Food and Drug Administration of its voluntary withdrawal and is also in the process of notifying health care practitioners via telephones, ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK